Literature DB >> 12772949

Control of occupational asthma and allergy in the detergent industry.

Katherine Sarlo1.   

Abstract

OBJECTIVE: To provide an overview of how a comprehensive preclinical, clinical, and industrial hygiene program has been successfully used to control allergy and asthma to enzymes used in the detergent industry. DATA SOURCES: The author performed a PubMed and ToxLine search of English-language articles with the keywords enzymes, occupational allergy, occupational asthma, detergent, and detergent industry from January 1, 1995, to January 1, 2002. Scientific meeting abstracts, books, and industry association papers on allergy and asthma in the detergent industry were also reviewed. In addition, the practical experience of one major detergent company was included in the review. STUDY SELECTION: All published work on this topic was reviewed, and the work that discussed the key highlights of control of occupational allergy and asthma to enzymes used in the detergent industry was selected for this review.
RESULTS: The detergent industry has developed guidelines for the safety assessment of enzymes, control of exposure to enzymes, and medical surveillance of enzyme-exposed workers. Because of these guidelines, occupational allergy and asthma to enzymes used in the detergent industry have become uncommon events. Cases of disease have been documented in some manufacturing sites that have had poor adherence to the guidelines. Those manufacturing sites that have adhered to the guidelines have had few cases of allergy and asthma to enzymes among exposed workers. A review of medical data from these sites has shown that workers who have developed IgE antibody to enzymes can continue to work with enzymes and remain symptom free.
CONCLUSIONS: Occupational allergy and asthma to enzymes used in the detergent industry have been successfully controlled via the use of preclinical, clinical, and industrial hygiene safety programs designed to minimize sensitization to enzymes and development of disease. The basic principles of these programs can be applied to other industries where occupational allergy and asthma to proteins are common.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12772949     DOI: 10.1016/s1081-1206(10)61646-8

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  7 in total

Review 1.  Review of Diagnostic Challenges in Occupational Asthma.

Authors:  Jacques A Pralong; Andre Cartier
Journal:  Curr Allergy Asthma Rep       Date:  2017-01       Impact factor: 4.806

2.  Incidence of respiratory sensitisation and allergy to enzymes among employees in an enzyme producing plant and the relation to exposure and host factors.

Authors:  A I Larsen; C R Johnsen; J Frickmann; S Mikkelsen
Journal:  Occup Environ Med       Date:  2007-11       Impact factor: 4.402

3.  Healthcare for obstructive lung disease in an industrial spirometry surveillance program.

Authors:  Mridu Gulati; Martin D Slade; Martha G Fiellin; Mark R Cullen
Journal:  J Occup Environ Med       Date:  2009-03       Impact factor: 2.162

4.  Industrial fungal enzymes: an occupational allergen perspective.

Authors:  Brett J Green; Donald H Beezhold
Journal:  J Allergy (Cairo)       Date:  2011-06-21

5.  Managing the Risk of Occupational Allergy in the Enzyme Detergent Industry.

Authors:  David A Basketter; Francis H Kruszewski; Sophie Mathieu; Donald Bruce Kirchner; Anthony Panepinto; Mark Fieldsend; Volker Siegert; Fiona Barnes; Robert Bookstaff; Merete Simonsen; Beth Concoby
Journal:  J Occup Environ Hyg       Date:  2015       Impact factor: 2.155

6.  Experiences from occupational exposure limits set on aerosols containing allergenic proteins.

Authors:  Gunnar D Nielsen; Søren T Larsen; Jitka S Hansen; Lars K Poulsen
Journal:  Ann Occup Hyg       Date:  2012-07-28

Review 7.  EAACI position paper on occupational rhinitis.

Authors:  Gianna Moscato; Olivier Vandenplas; Roy Gerth Van Wijk; Jean-Luc Malo; Luca Perfetti; Santiago Quirce; Jolanta Walusiak; Roberto Castano; Gianni Pala; Denyse Gautrin; Hans De Groot; Ilenia Folletti; Mona Rita Yacoub; Andrea Siracusa
Journal:  Respir Res       Date:  2009-03-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.